ShareHope Medicine (8403.TWO) Earnings Analysis
ShareHope Medicine (8403.TWO) next reports earnings on 2026-08-07, consensus EPS 0.626 TWD. Last quarter (2026-03-13) it missed with EPS 0.38 TWD vs 0.657 TWD est (-42.2%). It has beaten estimates in 0/1 recent quarters (0%). Trailing P/E 20.47.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 8403.TWO next report earnings?
| Next earnings date | 2026-08-07 |
|---|---|
| Consensus EPS estimate | 0.626 TWD |
| Revenue estimate | 1.08B |
8403.TWO earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-03-13 | 0.38 TWD | 0.657 TWD | -42.2% | Miss |
| 2025-09-30 | 0.23 TWD | n/a | n/a | n/a |
| 2025-06-30 | 0.21 TWD | n/a | n/a | n/a |
| 2025-03-31 | 0.24 TWD | n/a | n/a | n/a |
| 2024-12-31 | 0.664 TWD | n/a | n/a | n/a |
| 2024-09-30 | 0.13 TWD | n/a | n/a | n/a |
Beat rate: 0/1 (0%) over reported quarters with consensus data.
8403.TWO valuation and analyst view
| Trailing P/E | 20.47 |
|---|---|
| Trailing EPS | 1.771 TWD |
| Price / book | 0.43 |
| Dividend yield | 2.57% |
| Market cap | 2.66B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is ShareHope Medicine (8403.TWO)'s next earnings date?
ShareHope Medicine is next scheduled to report on 2026-08-07, with a consensus EPS estimate of 0.626 TWD and revenue estimate of 1.08B.
Did 8403.TWO beat earnings last quarter?
In its 2026-03-13 report, 8403.TWO posted EPS of 0.38 TWD versus a 0.657 TWD estimate — a miss of 42.2%.
What is 8403.TWO's earnings track record?
Over the last 1 reported quarters with consensus data, 8403.TWO beat estimates 0 times (0%).
What is 8403.TWO's current P/E ratio and EPS?
8403.TWO trades at a trailing P/E of 20.47 on trailing EPS of 1.7707577883062915 TWD.
What do analysts rate 8403.TWO?
8403.TWO has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.